Systemic therapy for Asian patients with advanced BRAF V600‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (B‐CHECK‐RWD study)

BACKGROUND: Anti‐PD‐1‐based immunotherapy is considered a preferred first‐line treatment for advanced BRAF V600‐mutant melanoma. However, a recent international multi‐center study suggested that the efficacy of immunotherapy is poorer in Asian patients in the non‐acral cutaneous subtype. We hypothes...

Descripción completa

Detalles Bibliográficos
Autores principales: Namikawa, Kenjiro, Ito, Takamichi, Yoshikawa, Shusuke, Yoshino, Koji, Kiniwa, Yukiko, Ohe, Shuichi, Isei, Taiki, Takenouchi, Tatsuya, Kato, Hiroshi, Mizuhashi, Satoru, Fukushima, Satoshi, Yamamoto, Yosuke, Inozume, Takashi, Fujisawa, Yasuhiro, Yamasaki, Osamu, Nakamura, Yasuhiro, Asai, Jun, Maekawa, Takeo, Funakoshi, Takeru, Matsushita, Shigeto, Nakano, Eiji, Oashi, Kohei, Kato, Junji, Uhara, Hisashi, Miyagawa, Takuya, Uchi, Hiroshi, Hatta, Naohito, Tsutsui, Keita, Maeda, Taku, Matsuya, Taisuke, Yanagisawa, Hiroto, Muto, Ikko, Okumura, Mao, Ogata, Dai, Yamazaki, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524053/
https://www.ncbi.nlm.nih.gov/pubmed/37584204
http://dx.doi.org/10.1002/cam4.6438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524053/
https://www.ncbi.nlm.nih.gov/pubmed/37584204
http://dx.doi.org/10.1002/cam4.6438

Ejemplares similares